Top compounds associated with response to HILPDA


Feature Type Standardized
Nominal ANOVA
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA EX-527 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA TAE684 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.023 0.7
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.021 0.7
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
Download CSV